Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.5M |
 |
Gilead SciencesGILD |
-$4.04B |
 |
AmgenAMGN |
-$189M |
 |
Editas MedicineEDIT |
-$7M |
 |
Crispr TherapeuticsCRSP |
-$171M |
Are Genprex Insiders Buying or Selling?
Genprex (GNPX) has had no reported insider transactions in the past 90 days. The most recent was BRENT LONGNECKER, who sold 10 shares at $1.23 on April 14, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the GNPX AI Score. For government officials trading this stock, see GNPX congressional trading.
Who’s Trading Genprex Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| BRENT LONGNECKER | Sold $22 | 2 | Apr 14, 2026 |
Recent Genprex Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| BRENT LONGNECKER | Apr 14, 2026 | Sell | 10 | $1.23 | $12 |
| BRENT LONGNECKER | Apr 14, 2026 | Sell | 8 | $1.23 | $10 |
Frequently Asked Questions: Genprex Insider Trading
Genprex insiders have not reported any transactions in the past 90 days.
The most recent sale was by BRENT LONGNECKER who sold 10 shares on April 14, 2026. View all transactions in the table on this page.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
LONGNECKER BRENT M has sold the most GNPX stock in the last 2 years, with a total value of $22.
The total value of insider transactions for Genprex in the last 2 years is negative, amounting to -$22. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
